Amgen presents data from several romosozumab and Prolia at ASBMR 2013 Annual Meeting
Amgen today announced that it will present data from several romosozumab and Prolia® (denosumab) studies at the American Society for Bone and Mineral Research (ASBMR) 2013 Annual Meeting in Baltimore from Oct. 4-7, 2013.